Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00379782 · ClinicalTrials.gov registry record · NA
Kukui Ahi Navigator Cancer Screening and Treatment Demonstration Project
A NA study, sponsored by Queen's Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 628
- Enrollment target
NCT00379782: Completed NA study, sponsored by Queen's Medical Center.
NCT00379782 is a NA study that has completed, run by Queen's Medical Center. The registered enrollment target is 628 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00379782, a NA study, has completed, sponsored by Queen's Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 628 participants
- Enrollment target
Study Summary
This Cancer Prevention and Treatment Demonstration Project funded by the Centers of Medicare and Medicaid Services awarded six sites across the United States to develop Patient Navigator Programs to eliminate disparities in the rate of preventative cancer screening and timely diagnosis and treatment of cancer for racial and ethnic minorities. This site of Molokai General Hospital are focused on Pacific Islanders and Asian Americans. This program called Kukui Ahi propose to increase screening and early detection for four targeted cancers-breast, cervical, colorectal, and prostate- with lung cancer additionally being included in treatment protocols to improve outcomes and satisfaction by employing a culturally appropriate navigation protocol to facilitate utilization of healthcare services and decrease health barriers. The specific aims of the project is to: 1. Determine if a Navigator Program can reduce the proportion of the targeted cancers diagnosed at a late stage, 2. Determine if the Navigator Program can improve the continuity of health care for cancer patients, 3. Determine if the Navigator Program can improve quality of life and subjective well being of navigated cancer patients, 4. Determine if the Navigator Program is a cost-effective way to reduce cancer care disparities for screenable cancers.
Interventions
- OTHER Navigation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 628 participants |
| Start Date | 2006-10 |
| Est. Completion | 2011-03 |
| Phase | NA |
What the finished NCT00379782 record still lists
NCT00379782 is an interventional study that assigns participants to a tested intervention. The registered 628 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower).
The record links to 0 conditions, and to 1 intervention - of which Navigation is the first listed.
NCT00379782 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00379782 about?
NCT00379782 is a clinical study titled "Kukui Ahi Navigator Cancer Screening and Treatment Demonstration Project". This Cancer Prevention and Treatment Demonstration Project funded by the Centers of Medicare and Medicaid Services awarded six sites across the United States to develop Patient Navigator Programs to eliminate disparities in the rate of preventative cancer screening and timely diagnosis and treatment...
What is the current status of trial NCT00379782?
This trial is currently completed. It is a NA study. The enrollment target is 628 participants. The study started on 2006-10. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00379782?
The interventions under investigation include: Navigation (OTHER).
Who is sponsoring clinical trial NCT00379782?
This trial is sponsored by Queen's Medical Center, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00379782's enrollment target sits among peer trials
628 160th of 2000 higher than 1,841 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04704921 · 630 participants · Phase 2
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD
- NCT04707729 · 630 participants · NA
ROX Index for the Timing of Intubation in Nasal High Flow
- NCT05061550 · 630 participants · Phase 2
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
- NCT05224440 · 630 participants · NA
National Sponsorship Program for Transitioning Service Members
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia